Marked and Durable Response to DLL3-Directed T-Cell Engager Tarlatamab in a Patient With Metastatic Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report
1. 系统已在2026-06-30 13:16:18对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.cllc.2026.03.006
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1525730426000409
其他信息:
出版社: Elsevier BV
作者: Hagop Tashjian; Sether Johnson; Ramzi Hamouche; Poornima Hegde; Yueming Chang

